Investors' Claims Against NEA Funds Likely To Survive
Some damage claims against venture capital giant New Enterprise Associates are likely to survive dismissal arguments in a dispute over NEA's alleged conflicted exploitation of its hold on a medical technology...To view the full article, register now.
Already a subscriber? Click here to view full article